2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Print

Mini-Oral Session

[MO24] Mini-Oral Session 24　Genitourinary Cancer

Fri. Feb 18, 2022 2:05 PM - 2:55 PM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair：Aiko Maejima（Department of Urology, National Cancer Center Hospital），Yuji Miura（Department of Medical Oncology, Toranomon Hospital）

[MO24-1] Comparison of Nivo-Ipi versus TKIs as first line therapy for mRCC : Real-world data from multicenter retrospective study

○Noriyoshi Miura1, Shinsuke Mouri1, Akihiro Maeda1, Kenichi Nishimura1, Yuki Miyauchi1, Tadahiko Kikugawa1, Sawada Yuichiro2, Tomida Ryotaro2, Matsumura Masafumi2, Hashine Katsuyoshi2, Yanagihara Yutaka3, Ninomiya Iku3, Kan Masaharu3, Asai Seiji4, Tacho Takatoshi4, Saika Takashi1 (1.Department of Urology, Ehime University Graduate School of Medicine, 2.Department of Urology, Shikoku Cancer Center, 3.Department of Urology, Ehime Prefectural Central Hospital, 4.Department of Urology, Matsuyama Red Cross Hospital)

[MO24-2] Clinical Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma

○Taigo Kato1, Akira Nagahara2, Norihiko Kawamura3, Wataru Nakata4, Tetsuji Soda5, Kyousuke Matsuzaki6, Koji Hatano1, Atsunari Kawashima1, Takeshi Ujike1, Kensaku Nishimura6, Shingo Takada5, Masao Tsujihata4, Seiji Yamaguchi3, Tetsuya Takao3, Yasutomo Nakai2, Masashi Nakayama2, Motohide Uemura1, Norio Nonomura1 (1.Department of Urology, Osaka University Graduate School of Medicine, 2.Department of Urology, Osaka International Cancer Institute, 3.Department of Urology, Osaka General Medical Center, 4.Department of Urology, Osaka Rosai Hospital, 5.Department of Urology, Osaka Police Hospital, 6.Department of Urology, National Hospital Organization Osaka National Hospital)